Genpact Ltd is not a strong buy at the moment for a beginner investor with a long-term focus. The stock is currently in a bearish trend, with significant price declines and no strong positive catalysts to suggest a reversal. Analysts have lowered price targets, hedge funds are selling, and there are no recent signals from proprietary trading tools. While the RSI indicates the stock is oversold, the overall sentiment and lack of clear growth drivers make it prudent to hold off on buying.
The stock is in a bearish trend with MACD negatively expanding (-0.271), RSI at 15.639 indicating oversold conditions, and bearish moving averages (SMA_200 > SMA_20 > SMA_5). Key support is at 28.443, with resistance at 30.711. The stock closed at 28.45, near its support level.

NULL identified. The RSI suggests the stock is oversold, which could indicate a potential rebound, but this is not supported by other data.
Significant price decline (-6.80% in regular market), hedge funds are selling (805.73% increase in selling), analysts have consistently lowered price targets, and no significant insider or congress trading activity. News highlights challenges in addressing enterprise debts, which may hinder growth.
No financial data available for the latest quarter. However, analysts noted decelerating growth in core business services for the fifth straight quarter.
Analysts have lowered price targets multiple times recently, with ratings remaining Neutral. Price targets range from $32 to $45, reflecting a cautious outlook.